Today we shared preliminary clinical study data from one of our lead therapeutic candidates, SRF388, at the @ASCO Annual Meeting: https://t.co/ifFXTFCy0M #ASCO21 https://t.co/vkam1rs0kK
Today we shared preliminary clinical study data from one of our lead therapeutic candidates, SRF388, at the @ASCO Annual Meeting: https://t.co/ifFXTFCy0M #ASCO21 https://t.co/vkam1rs0kK